CN104799276A - 一种麻七利血溶栓粉及其制备方法 - Google Patents
一种麻七利血溶栓粉及其制备方法 Download PDFInfo
- Publication number
- CN104799276A CN104799276A CN201510149858.9A CN201510149858A CN104799276A CN 104799276 A CN104799276 A CN 104799276A CN 201510149858 A CN201510149858 A CN 201510149858A CN 104799276 A CN104799276 A CN 104799276A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- thrombolysis
- blood
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 66
- 210000004369 blood Anatomy 0.000 title claims abstract description 65
- 239000000843 powder Substances 0.000 title claims abstract description 44
- 230000002537 thrombolytic effect Effects 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 230000001737 promoting effect Effects 0.000 title abstract description 15
- 230000004087 circulation Effects 0.000 title abstract description 7
- 241000305491 Gastrodia elata Species 0.000 title abstract 3
- 235000003143 Panax notoginseng Nutrition 0.000 title abstract 3
- 241000180649 Panax notoginseng Species 0.000 title abstract 3
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 244000131316 Panax pseudoginseng Species 0.000 claims description 18
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 18
- 241000723353 Chrysanthemum Species 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 16
- 240000007164 Salvia officinalis Species 0.000 claims description 16
- 235000005412 red sage Nutrition 0.000 claims description 16
- 235000013372 meat Nutrition 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 11
- 238000005728 strengthening Methods 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 5
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 230000002936 tranquilizing effect Effects 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- 238000009499 grossing Methods 0.000 abstract 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000209020 Cornus Species 0.000 abstract 1
- 206010039424 Salivary hypersecretion Diseases 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000004377 improving vision Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000026451 salivation Diseases 0.000 abstract 1
- 210000002435 tendon Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000003218 coronary vasodilator agent Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008557 oxygen metabolism Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013980 Dyssomnias Diseases 0.000 description 1
- 208000031969 Eye Hemorrhage Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000008727 tongluo Substances 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510149858.9A CN104799276B (zh) | 2015-04-01 | 2015-04-01 | 一种麻七利血溶栓粉及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510149858.9A CN104799276B (zh) | 2015-04-01 | 2015-04-01 | 一种麻七利血溶栓粉及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104799276A true CN104799276A (zh) | 2015-07-29 |
| CN104799276B CN104799276B (zh) | 2017-01-18 |
Family
ID=53684834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510149858.9A Expired - Fee Related CN104799276B (zh) | 2015-04-01 | 2015-04-01 | 一种麻七利血溶栓粉及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104799276B (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343570A (zh) * | 2015-11-27 | 2016-02-24 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | 一种补气养血的中药配方 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097331A (zh) * | 1994-05-06 | 1995-01-18 | 孟昭轩 | 抗栓益寿酒及其配制方法 |
| CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
| US20110160153A1 (en) * | 2009-12-31 | 2011-06-30 | Guihua Lan | Methods and Compositions for Treating Blood Circulation Disorders |
| CN103479895A (zh) * | 2013-09-12 | 2014-01-01 | 芦玉明 | 一种舒心清脑中药组合物 |
| CN104225275A (zh) * | 2014-09-09 | 2014-12-24 | 青岛市市立医院 | 一种治疗脑血栓的中药组合物及其制备方法 |
-
2015
- 2015-04-01 CN CN201510149858.9A patent/CN104799276B/zh not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097331A (zh) * | 1994-05-06 | 1995-01-18 | 孟昭轩 | 抗栓益寿酒及其配制方法 |
| CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
| US20110160153A1 (en) * | 2009-12-31 | 2011-06-30 | Guihua Lan | Methods and Compositions for Treating Blood Circulation Disorders |
| CN103479895A (zh) * | 2013-09-12 | 2014-01-01 | 芦玉明 | 一种舒心清脑中药组合物 |
| CN104225275A (zh) * | 2014-09-09 | 2014-12-24 | 青岛市市立医院 | 一种治疗脑血栓的中药组合物及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343570A (zh) * | 2015-11-27 | 2016-02-24 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | 一种补气养血的中药配方 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104799276B (zh) | 2017-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103976243A (zh) | 一种补气养血保健粥及其制备方法 | |
| CN103585516A (zh) | 一种调治阳虚体质的中药组合物及中药调理膏 | |
| CN109847027A (zh) | 一种固本化痰降脂中药组合物及其制剂的制备工艺 | |
| CN103736072B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
| CN101716242A (zh) | 一种治疗心脑血管疾病的中药 | |
| CN104524440B (zh) | 一种用于女性内分泌紊乱调理的药丸及制备方法 | |
| CN102727711B (zh) | 一种治疗慢性疲劳综合症的中药 | |
| CN101461907A (zh) | 一种治疗肝阳上亢、熄肝风、滋肾阴药物及制备方法 | |
| CN104069446A (zh) | 一种治疗冠心病心绞痛的中药组合物 | |
| CN103013806B (zh) | 一种保健治疗中药醋 | |
| CN106880826A (zh) | 一种治疗慢性心力衰竭的中药制剂及其制备方法 | |
| CN103202956A (zh) | 一种降血压养生保健药酒 | |
| CN104799276B (zh) | 一种麻七利血溶栓粉及其制备方法 | |
| CN105816750A (zh) | 一种调治气虚体质的中药组合物及中药调理膏 | |
| CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
| CN105456710B (zh) | 一种活血降脂药及其制备方法 | |
| CN105833172A (zh) | 用于治疗无症状性心肌缺血的中药冲剂及制备方法 | |
| CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
| CN104922504A (zh) | 治疗动脉粥样硬化的醋饮及制备方法 | |
| CN114767794B (zh) | 一种治疗动脉斑块的中药 | |
| CN102861223A (zh) | 七味糖尿胶囊 | |
| CN101675802A (zh) | 中药汁渗入红枣预防治疗多种疾病及其制作方法——药膳枣 | |
| CN1966050A (zh) | 一种治疗心脏病的药物及制备方法 | |
| CN106729169A (zh) | 桑鳝降糖降脂降压胶囊 | |
| CN104740478A (zh) | 一种用于急诊处理酒精中毒征的中药丸剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: XIA MINGYUE Free format text: FORMER OWNER: LI SHAOBAI Effective date: 20150805 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Xia Mingyue Inventor before: Li Shaobai |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI SHAOBAI TO: XIA MINGYUE |
|
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150805 Address after: 266000 Shandong Province, Qingdao city Nanjing Road 35 No. 2 unit 501 B Applicant after: Xia Mingyue Address before: Licang District Shengping road 266000 Shandong city of Qingdao Province, No. 61 Building No. 2 Applicant before: Li Shaobai |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170118 Termination date: 20200401 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |